Centerline Biomedical
                                                                                                                                    
                                                                                                United States
                                                 -                                                 Cleveland, Ohio
                                                                                            
                                                                                    - 27/06/2022
 - Series B
 - $33,000,000
 
A New Way to Envision Interventional Navigation
- Industry Medical Equipment Manufacturing
 - Website https://centerlinebiomedical.com/
 - LinkedIn https://www.linkedin.com/company/centerline-biomedical/about/
 
Related People
Philip D. RackliffeFounder
                                                    
                                                                                                                United States -
                                                         Cleveland, Ohio
                                                    
                                                • 25 years of global healthcare leadership and executive management in medical device, medical technology and pharmaceutical industries spanning public and private sectors
• Successfully grew and scaled companies from start-ups to large multi-nationals, raised millions in capital and bought/sold assets totaling over $1B in proceeds
• General management and P&L ownership from start-ups to company divisions with over $2 billion in annual revenue
• Corporate leadership roles across strategy, sales, marketing (upstream and downstream), business development, operations and global franchises
• Launched more than 50 life sciences products that span both medical device and pharmaceutical sectors
• Keen focus on building strong team cultures by employing a diverse workforce and valuing inclusion at all levels of the organization
• Significant experience in M&A by acquiring and divesting businesses to help drive business synergies
• Extensive international business experience across developed and emerging markets; leading and closing deals in the US, Europe, India, China, Taiwan, Korea and Brazil
• Proven influence capabilities to advance complex business initiatives across a matrixed organization
• Competitive leader that constantly seeks to maximize value for patients and shareholders
• Strong customer intimacy skills gained from starting as a sales professional
• Proud father of two high school aged children, a practicing physician wife and avid tennis player 
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                Zeeg |  $1,265,935  | (Nov 4, 2025)
                            
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                    
                                    
                                    
                                    
                                    
                                    
                                    
                                    
                                            
                                                
                                                
                                                
                                                    
                                                
                                                
                                                    
                                                
                                                
                                                
                                                    
                                                
                                                
                                                    
                                                                        
                                Cephia AI |  $4,000,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)
                                                                        
                                octonomy |  $20,000,000  | (Nov 4, 2025)
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                Indomo |  $25,000,000  | (Nov 4, 2025)
                                                                        
                                AUI™ (Augmented Intelligence) |  $20,000,000  | (Nov 4, 2025)
                                                                        
                                Popai Health |  $11,000,000  | (Nov 4, 2025)
                                                                        
                                Mem0 |  $24,000,000  | (Oct 30, 2025)
                                                                        
                                FrontlineIQ |  $3,300,000  | (Oct 30, 2025)